Calcitriol Capsule, Liquid Filled
NDC Package 70518-4775-0

11-digit billing NDC: 70518477500

Package Information

Calcitriol capsules is calcitriol should not be given to patients with hypercalcemia or evidence of vitamin D toxicity. This formulation utilizes a capsule, liquid filled delivery system. Marketed by Remedyrepack Inc., this product is identified by NDC 70518-4775 and is authorized under FDA application ANDA091174.

Identification & Billing

NDC Package Code
70518-4775-0
Package Description
90 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC
Product Code
11-Digit Billing Format
70518477500

Clinical Specifications

Proprietary Name
Calcitriol
Non-Proprietary Name
Calcitriol
Substance Name
Calcitriol
Dosage Form
Capsule, Liquid Filled - A solid dosage form in which the drug is enclosed within a soluble, gelatin shell which is plasticized by the addition of a polyol, such as sorbitol or glycerin, and is therefore of a somewhat thicker consistency than that of a hard shell capsule; typically, the active ingredients are dissolved or suspended in a liquid vehicle.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Usage Information
Calcitriol should not be given to patients with hypercalcemia or evidence of vitamin D toxicity. Use of calcitriol in patients with known hypersensitivity to calcitriol (or drugs of the same class) or any of the inactive ingredients is contraindicated.

Regulatory & Marketing

Labeler Name
Remedyrepack Inc.
Product Type
Human Prescription Drug
FDA Application #
ANDA091174
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
10-15-2026
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 70518-4775-0 identifies a specific commercial package of 90 capsule, liquid filled in 1 bottle, plastic of Calcitriol, a human prescription drug labeled by Remedyrepack Inc.. This capsule, liquid filled is formulated for oral use and contains calcitriol as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Remedyrepack Inc. on October 15, 2026. The current certification is valid through December 31, 2027.

How is this Remedyrepack Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 70518477500. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
70518-4775-0
11-Digit CMS (5-4-2)
70518-4775-00

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.